Graft-versus-host disease cost-effectiveness of therapy: Difference between revisions
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
Corticosteroids are the most cost-effective therapy for GvHD. Prednisone and methylprednisolone are available at very low cost. Second-line therapies and cell-based therapies are significantly more expensive. If corticosteroids can be used, these should be given first. | [[Corticosteroids]] are the most cost-effective therapy for GvHD. [[Prednisone]] and [[methylprednisolone]] are available at very low cost. Second-line therapies and [[cell-based therapies]] are significantly more expensive. If [[corticosteroids]] can be used, these should be given first. | ||
==References== | ==References== | ||
Revision as of 20:32, 22 June 2017
|
Graft-versus-host disease |
|
Differentiating Graft-versus-host disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Graft-versus-host disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Graft-versus-host disease cost-effectiveness of therapy |
|
FDA on Graft-versus-host disease cost-effectiveness of therapy |
|
CDC on Graft-versus-host disease cost-effectiveness of therapy |
|
Graft-versus-host disease cost-effectiveness of therapy in the news |
|
Blogs on Graft-versus-host disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Graft-versus-host disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cost-Effectiveness of Therapy
Corticosteroids are the most cost-effective therapy for GvHD. Prednisone and methylprednisolone are available at very low cost. Second-line therapies and cell-based therapies are significantly more expensive. If corticosteroids can be used, these should be given first.